Film-coated tablet: Moxifloxacin (Xiflox) tablets are indicated for the treatment of the following bacterial infections in patients of 18 years and older caused by bacteria susceptible to moxifloxacin.
Respiratory tract infections: Acute bacterial sinusitis; Acute exacerbations of chronic bronchitis; Community acquired pneumonia, including CAP caused by multi-drug resistant strains.
Uncomplicated skin and skin structure infections.
Uncomplicated pelvic inflammatory disease (i.e. infections of female upper genital tract, including salpingitis and endometritis).
Complicated skin and skin structure infections (including diabetic foot infections).
Complicated intraabdominal infections including polymicrobial infections such as abscesses.
Solution for injection: Moxifloxacin (XIFLOX) IV is indicated for the treatment of adults (>18 years of age) with mild, moderate and severe infections caused by susceptible strains of micro-organisms in the conditions as follows: Acute bacterial sinusitis, Acute bacterial exacerbation of chronic bronchitis, Community acquired pneumonia, Uncomplicated skin and skin structure infections, Complicated intra-abdominal infections (including polymicrobial infections such as abscesses), Complicated skin and skin structure infections (including diabetic foot infections).
Other Services
Country
Account